Matinas BioPharma Holdings Inc. (MTNB) Rises After Hours Thanks to Programs Update and 2022 Outlook
On January 25, Matinas BioPharma Holdings Inc. (MTNB) provided an ongoing program update along with the outlook for 2022. Consequently, the stock became bullish in